Projected health-care resource needs for an effective response to COVID-19 in 73 low-income and middle-income countries: a modelling study

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30383-1/fulltext?dgcid=hubspot_email_newsletter_tlcoronavirus20&utm_campaign=tlcoronavirus20&utm_medium=email&_hsmi=94963858&_hsenc=p2ANqtz-_0TLn4OovcryIx7dp0Pu6ouGCv5C2Nz-VhpKzGhMzk-x2GYg_AoYQxmlq2XYVhbCPPjCK-_vHXY4MJa4Csh_euyDRaQA&utm_content=94963858&utm_source=hs_email

Dear Victor Norberto,

Editor's Pick: An Article in The Lancet Global Health discusses the costs of pandemic preparedness if current COVID-19 transmission levels are maintained or scenarios where transmission is increased or decreased by 50%. The modelling study projected the number of COVID-19 cases for 73 LMICs for each scenario for both 4 and 12-week timeframes. The cost estimate for the COVID-19 response if transmission levels are maintained is US$52∙45 billion over 4 weeks. For decreased or increased transmission scenarios, the total is US$33∙08 billion and US$61∙92 billion respectively, with costs tripling under the 12 weeks scenarios. The main cost drivers were clinical case management (54%), maintaining essential services (21%), rapid response and case investigation
(14%), and infection prevention and control (9%). The authors assert that sizeable costs of a COVID-19 response in the health sector will escalate, particularly if transmission increases, highlighting the importance of working to reduce virus transmission and contain costs. Read the Article here.

We hope you find the Resource Centre on COVID-19 to be informative. 

We want to make sure that you receive information that is interesting and relevant to you, so if you prefer to receive updates to include new Chinese translations please click here.

Yours sincerely,

The Lancet

NEW content on COVID-19

The Lancet Global Health Projected health-care resource needs for an effective response to COVID-19 in 73 low-income and middle-income countries: a modelling study Open Access The Lancet Planetary Health Walking forwards, looking backwards Open Access Post-pandemic recovery: use of scientific advice to achieve social equity, planetary health, and economic benefits Open Access Targeted change making for a healthy recovery Open Access Will the COVID-19 crisis trigger a One Health coming-of-age? Open Access Responding to COVID-19 requires strong epidemiological evidence of environmental and societal determining factors Open Access The Lancet Rheumatology COVACTA trial raises questions about tocilizumab's benefit in COVID-19